Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise

TUESDAY, May 26, 2020 -- A recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine is safe, tolerable, and immunogenic, according to a study published online May 22 in The Lancet. Feng-Cai Zhu, Ph.D., from the Jiangsu Provincial Center for...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news